Patents-Review.com
ClassID:

95271 ⎘

C07D409/02 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings

Sub-classes:
Recent Application in this class:
#1
20250275952
2025-09-04

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

 #2
20230113588
2023-04-13

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF

 #3
20220117955
2022-04-21

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

 #4
20210053954
2021-02-25

AROMATIC AMINE COMPOUND, COVERING LAYER MATERIAL, AND LIGHT-EMITTING ELEMENT

 #5
20200347021
2020-11-05

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

 #6
20200345716
2020-11-05

4-methylsulfonyl-substituted piperidine urea compounds

 #7
20200113887
2020-04-16

4-methylsulfonyl-substituted piperidine urea compounds

 #8
20190276423
2019-09-12

Tricyclic heterocyclic derivatives and uses thereof

 #9
20190269669
2019-09-05

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

 #10
20190062300
2019-02-28

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

 #11
20190016715
2019-01-17

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

 #12
20170362196
2017-12-21

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

 #13
20170294590
2017-10-12

Organic electroluminescent compound, and organic electroluminescent material and organic electroluminescent device comprising the same

 #14
20170217951
2017-08-03

Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof

 #15
20160243100
2016-08-25

4-methylsulfonyl-substituted piperidine urea compounds

 #16
20160102071
2016-04-14

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

 #17
20150331314
2015-11-19

PATTERN FORMING METHOD, COMPOUND USED THEREIN, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE

 #18
20150210800
2015-07-30

Synthesis of photovoltaic conjugated polymers

 #19
20140336200
2014-11-13

Arylosulfonamides for the treatment of CNS diseases

 #20
20140094610
2014-04-03

PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR

 #21
20130214213
2013-08-22

Synthesis of photovoltaic conjugated polymers

 #22
20130172365
2013-07-04

Arylosulfonamides for the treatment of CNS diseases

 #23
20120237874
2012-09-20

Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition

 #24
20110200935
2011-08-18

Photoresist composition

 #25
20110077408
2011-03-31

Organic dye used in dye-sensitized solar cell

 #26
20110027716
2011-02-03

ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION, COMPOUND AND METHOD OF FORMING PATTERN USING THE COMPOSITION

 #27
20100029648
2010-02-04

11-Beta HSD1 Inhibitors

 #28
20090233944
2009-09-17

Pyrazine-2-carboxyamide derivatives

 #29
20090043103
2009-02-12

Organic dye used in dye-sensitized solar cell

 #30
20080214612
2008-09-04

Selective estrogen receptor modulators containing a phenylsulfonyl group

 #31
20070219198
2007-09-20

11-beta HSD1 inhibitors

 #32
20070179180
2007-08-02

Novel m3 muscarinic acetylcholine receptor antagonists

 #33
20070073052
2007-03-29

Organic dye used in dye-sensitized solar cell

 #34
20060199828
2006-09-07

Pyrazine-2-carboxyamide derivatives

 #35
20060183736
2006-08-17

Selective estrogen receptor modulators containing a phenylsulfonyl group

 #36
20060069103
2006-03-30

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

 #37
20060014755
2006-01-19

17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases